By rray, 26 January, 2024 Exclude Patient Type Detail Header No Detail Type Text Detail Text Use validated score e g CHA2DS2 VASc If male pt w CHA2DS2 VASc score of 1 or female pt w CHA2DS2 VASc score of 2 remains uncertain about the benefit of anticoagulation consider other factors that might modify their stroke risk to help inform the decision Stroke risk is based on score and risk factors not AF pattern If congenital heart dz or HCM anticoagulate regardless of stroke risk score Re evaluate annually Evaluate for bleeding risks prior bleeding anemia meds Bleeding risk scores perform poorly Do not use in isolation ESC recommends HAS BLED score 1 Contraindications to long term anticoagulation nbsp nbsp Severe bleeding due to a nonreversible cause involving the GI pulmonary or GU systems nbsp nbsp Spontaneous intracranial intraspinal bleeding due to a nonreversible cause nbsp nbsp Serious bleeding Long term anticoagulation reasonable if nbsp nbsp Treatable GI pulmonary or GU system nbsp nbsp Bleeding related to isolated trauma nbsp nbsp Bleeding related to procedural complications Patient Type Detail Header (Long) Risk stratification for thrombosis risk and anticoagulation: